Marketplace Dynamics: Therapeutic Area of Choice assesses the current and future access and prescribing landscape for treatments to support effective identification of opportunities and risks for brands.
What level of influence do payers and organized providers have on access in the drugs market?
How will payer and organized provider management and contracting for branded drugs evolve over the next two years, and how should companies prepare for these changes?
How are payers responding to key events in the drugs market, such as new approvals and updated clinical data?
Use Marketplace Dynamics: Therapeutic Area of Choice to:
- Closely monitor market evolution
- Identify and monitor access shifts across the payer and organized provider segments
- Assess/predict payers' current and future management of the drugs market to facilitate development of effective strategies for inline/pipeline brand(s)
- Identify risks for brands, along with opportunities to improve access
-
Brand Access Landscape and Outlook 2024 - TA of Choice
- Landscape
- Road map for improving access for branded drugs in 2021
- Analysis of how stakeholders prioritize and manage the drug market
- Distribution Models and SP Utilization
- Evolution in distribution and site-of-administration management of drugs
- Role of SPs/PBMs in distribution, decision making, and drug therapy management
- Evolution of Contracting
- Impact and prevalence of contracting in the drug market
- Key contracting terms and success factors driving access gains for branded drugs
- Evolution of risk-based contracting agreements for branded drugs
- Future Outlook
- Predicted payer management tactics for therapies by 2024
- Brand access predictions based on detailed and likely future scenarios
- Landscape
-
Methodology
- Online quantitative survey
- 35-40 health plans; 30 integrated delivery networks (IDNs)
- Qualitative follow-up telephone interviews
- 5 health plans; 2-3 IDNs
- Online quantitative survey